LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 47.59 | 21.74 | 1 | 4492 | 0.0002 | -0.3299 | MN20160310_N01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 47.59 | 21.74 | 968 | 4492 | 0.2155 | 0.6382 | MN20160310_N01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 49.56 | 21.74 | 1 | 4838 | 0.0002 | -0.3262 | MN20160310_N01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 49.56 | 21.74 | 427 | 4838 | 0.0882 | 0.4650 | MN20160310_N01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 49.56 | 21.74 | 1 | 4838 | 0.0002 | -0.3262 | MN20160310_N01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 49.56 | 21.74 | 930 | 4838 | 0.1922 | 0.6188 | MN20160310_N01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 51.53 | 21.74 | 1 | 5150 | 0.0002 | -0.3232 | MN20160310_N01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 51.53 | 21.74 | 412 | 5150 | 0.0800 | 0.4520 | MN20160310_N01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 51.53 | 21.74 | 1 | 5150 | 0.0002 | -0.3232 | MN20160310_N01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 51.53 | 21.74 | 952 | 5150 | 0.1848 | 0.6147 | MN20160310_N01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 53.50 | 21.74 | 1 | 5425 | 0.0002 | -0.3207 | MN20160310_N01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 53.50 | 21.74 | 391 | 5425 | 0.0721 | 0.4374 | MN20160310_N01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 53.50 | 21.74 | 1 | 5425 | 0.0002 | -0.3207 | MN20160310_N01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 53.50 | 21.74 | 919 | 5425 | 0.1694 | 0.6003 | MN20160310_N01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 55.48 | 21.74 | 1 | 5768 | 0.0002 | -0.3178 | MN20160310_N01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 55.48 | 21.74 | 371 | 5768 | 0.0643 | 0.4224 | MN20160310_N01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 55.48 | 21.74 | 1 | 5768 | 0.0002 | -0.3178 | MN20160310_N01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 55.48 | 21.74 | 908 | 5768 | 0.1574 | 0.5897 | MN20160310_N01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 57.45 | 21.74 | 1 | 6023 | 0.0002 | -0.3158 | MN20160310_N01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 57.45 | 21.74 | 371 | 6023 | 0.0616 | 0.4186 | MN20160310_N01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 57.45 | 21.74 | 1 | 6023 | 0.0002 | -0.3158 | MN20160310_N01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 57.45 | 21.74 | 886 | 6023 | 0.1471 | 0.5792 | MN20160310_N01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 59.42 | 21.74 | 1 | 6125 | 0.0002 | -0.3150 | MN20160310_N01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 59.42 | 21.74 | 360 | 6125 | 0.0588 | 0.4119 | MN20160310_N01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 59.42 | 21.74 | 1 | 6125 | 0.0002 | -0.3150 | MN20160310_N01 | L09 |